Sclerotherapy for venous malformations

H. Mimura, K. Shibamoto, Y. Soda, K. Kojima, Yusuke Matsui, H. Fujiwara, Takao Hiraki, Hideo Gobara, Susumu Kanazawa

Research output: Contribution to journalArticle

Abstract

Sclerotherapy is a mainstay in the treatment of venous malformations (VMs). Indications for sclerotherapy of VMs include symptoms such as pain, swelling, hemorrhage, or dysfunction of adjacent organs. Ethanol and detergent sclerosants (for example polidocanol and ethanolamine oleate) are amongst the sclerosants used to treat VMs. To increase the volume and effect of detergent sclerosants, they may be mixed with gas to form a foam. The predictors of a good response after sclerotherapy may be small size, a well-defined margin, and good stasis of sclerosant during sclerotherapy.

Original languageEnglish
Pages (from-to)524-532
Number of pages9
JournalJapanese Journal of Clinical Radiology
Volume59
Issue number4
Publication statusPublished - 2014
Externally publishedYes

Fingerprint

Sclerosing Solutions
Sclerotherapy
Detergents
Ethanol
Gases
Hemorrhage
Pain

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Mimura, H., Shibamoto, K., Soda, Y., Kojima, K., Matsui, Y., Fujiwara, H., ... Kanazawa, S. (2014). Sclerotherapy for venous malformations. Japanese Journal of Clinical Radiology, 59(4), 524-532.

Sclerotherapy for venous malformations. / Mimura, H.; Shibamoto, K.; Soda, Y.; Kojima, K.; Matsui, Yusuke; Fujiwara, H.; Hiraki, Takao; Gobara, Hideo; Kanazawa, Susumu.

In: Japanese Journal of Clinical Radiology, Vol. 59, No. 4, 2014, p. 524-532.

Research output: Contribution to journalArticle

Mimura, H, Shibamoto, K, Soda, Y, Kojima, K, Matsui, Y, Fujiwara, H, Hiraki, T, Gobara, H & Kanazawa, S 2014, 'Sclerotherapy for venous malformations', Japanese Journal of Clinical Radiology, vol. 59, no. 4, pp. 524-532.
Mimura H, Shibamoto K, Soda Y, Kojima K, Matsui Y, Fujiwara H et al. Sclerotherapy for venous malformations. Japanese Journal of Clinical Radiology. 2014;59(4):524-532.
Mimura, H. ; Shibamoto, K. ; Soda, Y. ; Kojima, K. ; Matsui, Yusuke ; Fujiwara, H. ; Hiraki, Takao ; Gobara, Hideo ; Kanazawa, Susumu. / Sclerotherapy for venous malformations. In: Japanese Journal of Clinical Radiology. 2014 ; Vol. 59, No. 4. pp. 524-532.
@article{228678c1dcbd4fcd8a797227987ac85f,
title = "Sclerotherapy for venous malformations",
abstract = "Sclerotherapy is a mainstay in the treatment of venous malformations (VMs). Indications for sclerotherapy of VMs include symptoms such as pain, swelling, hemorrhage, or dysfunction of adjacent organs. Ethanol and detergent sclerosants (for example polidocanol and ethanolamine oleate) are amongst the sclerosants used to treat VMs. To increase the volume and effect of detergent sclerosants, they may be mixed with gas to form a foam. The predictors of a good response after sclerotherapy may be small size, a well-defined margin, and good stasis of sclerosant during sclerotherapy.",
author = "H. Mimura and K. Shibamoto and Y. Soda and K. Kojima and Yusuke Matsui and H. Fujiwara and Takao Hiraki and Hideo Gobara and Susumu Kanazawa",
year = "2014",
language = "English",
volume = "59",
pages = "524--532",
journal = "Japanese Journal of Clinical Radiology",
issn = "0009-9252",
publisher = "Kanehara Shuppan Co. Ltd",
number = "4",

}

TY - JOUR

T1 - Sclerotherapy for venous malformations

AU - Mimura, H.

AU - Shibamoto, K.

AU - Soda, Y.

AU - Kojima, K.

AU - Matsui, Yusuke

AU - Fujiwara, H.

AU - Hiraki, Takao

AU - Gobara, Hideo

AU - Kanazawa, Susumu

PY - 2014

Y1 - 2014

N2 - Sclerotherapy is a mainstay in the treatment of venous malformations (VMs). Indications for sclerotherapy of VMs include symptoms such as pain, swelling, hemorrhage, or dysfunction of adjacent organs. Ethanol and detergent sclerosants (for example polidocanol and ethanolamine oleate) are amongst the sclerosants used to treat VMs. To increase the volume and effect of detergent sclerosants, they may be mixed with gas to form a foam. The predictors of a good response after sclerotherapy may be small size, a well-defined margin, and good stasis of sclerosant during sclerotherapy.

AB - Sclerotherapy is a mainstay in the treatment of venous malformations (VMs). Indications for sclerotherapy of VMs include symptoms such as pain, swelling, hemorrhage, or dysfunction of adjacent organs. Ethanol and detergent sclerosants (for example polidocanol and ethanolamine oleate) are amongst the sclerosants used to treat VMs. To increase the volume and effect of detergent sclerosants, they may be mixed with gas to form a foam. The predictors of a good response after sclerotherapy may be small size, a well-defined margin, and good stasis of sclerosant during sclerotherapy.

UR - http://www.scopus.com/inward/record.url?scp=84899977746&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84899977746&partnerID=8YFLogxK

M3 - Article

VL - 59

SP - 524

EP - 532

JO - Japanese Journal of Clinical Radiology

JF - Japanese Journal of Clinical Radiology

SN - 0009-9252

IS - 4

ER -